Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bloch

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Plos One|September 9, 2017
Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)Kathy Petoumenos, Robin Huang, Jennifer Hoy, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2005
Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapyAlan Winston, Mark Bloch, Andrew Carr, et al.
International Journal of STD & AIDS|September 14, 2017
A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomesPedro E Ferrer, Mark Bloch, Norman Roth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological ReviewMark Bloch, Jody Kamminga, Avindra Jayewardene, et al.
International Journal of Transgender Health|October 28, 2024
Monitoring and reporting of adverse effects of testosterone prescribing for gender affirmation at general practice clinics - Data from the PUSH! AuditBeng Eu, Joshua Dawe, Matthew Dunn, et al.
Viral Immunology|April 1, 2011
Activation of NK cells by ADCC responses during early HIV infectionAmy W Chung, Marjon Navis, Gamze Isitman, et al.
Australian Journal of General Practice|April 6, 2023
Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs: The PUSH! AuditBeng Eu, Joshua Dawe, Matthew Dunn, et al.
Sexual Health|September 11, 2022
Physical function limitation among gay and bisexual men aged ≥55years with and without HIV: findings from the Australian Positive and Peers Longevity Evaluation Study (APPLES)David C Boettiger, Md Hamidul Huque, Mark Bloch, et al.
HIV Medicine|July 2, 2022
Are there additional adverse effects of testosterone use among men living with HIV?-Data from the PUSH! studyBeng Eu, Joshua Dawe, Matthew Dunn, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensionsNaomi Schlesinger, Rieke E Alten, Thomas Bardin, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Plos One|September 9, 2017
Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)Kathy Petoumenos, Robin Huang, Jennifer Hoy, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2005
Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapyAlan Winston, Mark Bloch, Andrew Carr, et al.
International Journal of STD & AIDS|September 14, 2017
A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomesPedro E Ferrer, Mark Bloch, Norman Roth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological ReviewMark Bloch, Jody Kamminga, Avindra Jayewardene, et al.
International Journal of Transgender Health|October 28, 2024
Monitoring and reporting of adverse effects of testosterone prescribing for gender affirmation at general practice clinics - Data from the PUSH! AuditBeng Eu, Joshua Dawe, Matthew Dunn, et al.
Viral Immunology|April 1, 2011
Activation of NK cells by ADCC responses during early HIV infectionAmy W Chung, Marjon Navis, Gamze Isitman, et al.
Australian Journal of General Practice|April 6, 2023
Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs: The PUSH! AuditBeng Eu, Joshua Dawe, Matthew Dunn, et al.
Sexual Health|September 11, 2022
Physical function limitation among gay and bisexual men aged ≥55years with and without HIV: findings from the Australian Positive and Peers Longevity Evaluation Study (APPLES)David C Boettiger, Md Hamidul Huque, Mark Bloch, et al.
HIV Medicine|July 2, 2022
Are there additional adverse effects of testosterone use among men living with HIV?-Data from the PUSH! studyBeng Eu, Joshua Dawe, Matthew Dunn, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensionsNaomi Schlesinger, Rieke E Alten, Thomas Bardin, et al.
Pageof 9